Pancreas
  • Can Your Diet Affect Your Risk for Gallstone-related Pancreatitis?

Can Your Diet Affect Your Risk for Gallstone-related Pancreatitis?

Consumption of red meat, saturated fat, and cholesterol increase risk for gallstone-related acute pancreatitis, researchers report in the February issue of Clinical Gastroenterology and Hepatology. Dietary fiber protects against acute pancreatitis—related and unrelated to gallstones—whereas coffee protects against acute pancreatitis not associated with gallstones, the study of thousands of patients

Read more
  • How Does Cigarette Smoking Lead to Chronic Pancreatitis?

How Does Cigarette Smoking Lead to Chronic Pancreatitis?

Aryl hydrocarbons in cigarette smoke activate an immune response that promotes pancreatic fibrosis and contributes to pancreatitis, researchers report in the December issue of Gastroenterology. The authors show that constituents of tobacco smoke activate signaling via the aryl hydrocarbon receptor (AHR) to induce T-cell production of interleukin 22 (IL22), activating

Read more
  • Why do Pancreatic Tumor Cells Love the Liver?

Why do Pancreatic Tumor Cells Love the Liver?

Pancreatic ductal adenocarcinoma (PDAC) and its precursors secrete high levels of tissue inhibitor of metalloproteinases 1 (TIMP1) into the circulation, which activates hepatic stellate cells (HSCs) in liver. These cells help create a niche that promotes metastasis of pancreatic tumors to liver, researchers report in the November issue of Gastroenterology.

Read more
  • CMGH now Searchable in PubMed!

CMGH now Searchable in PubMed!

Cellular and Molecular Gastroenterology and Hepatology (CMGH), published by the American Gastroenterological Association, has been accepted for indexing in PubMed Central, which will make all CMGH articles, starting with Volume 1, Issue 1, searchable as full text in PubMed over the next several weeks. In an editorial written for the September

Read more
  • A Mouse Model for Studying Pancreatic Tumor Resection and Adjuvant Therapy

A Mouse Model for Studying Pancreatic Tumor Resection and Adjuvant Therapy

Researchers have developed mice that develop focal, resectable pancreatic tumors closely resembling human pancreatic ductal adenocarcinomas (PDACs) that can be used to test adjuvant therapies, according to new research in the August issue of Gastroenterology. The authors show that administration of gemcitabine after resection of the tumors activates natural killer (NK) cell-mediated

Read more
  • Why Isn’t Radiation Therapy Effective for Pancreatic Tumors?

Why Isn’t Radiation Therapy Effective for Pancreatic Tumors?

In pancreatic tumors of mice, radiation causes infiltration by macrophages that acquire an immune-suppressive phenotype that disables T-cell–mediated anti-tumor responses, researchers report in the June issue of Gastroenterology. Blocking colony stimulating factor (CSF1 or MCSF) prevents this process, allowing radiation to slow tumor growth, they show. Most patients with pancreatic

Read more
  • Do NSAIDs Prevent PEP?

Do NSAIDs Prevent PEP?

Rectal indomethacin does not prevent pancreatitis following endoscopic retrograde cholangiopancreatography (ERCP), researchers report from a randomized controlled study published in the April issue of Gastroenterology. These findings contradict more than a decade of evidence that nonsteroidal anti-inflammatory drugs (NSAIDs) decrease the risk of post-ERCP pancreatitis (PEP). Acute pancreatitis is the

Read more

What is Causing the Increased Detection of Pancreatic Cysts?

Advances in imaging technologies over the past decades have greatly increased the numbers of pancreatic cysts detected, researchers report in the April issue of Clinical Gastroenterology and Hepatology. With further improvements in pancreatic imaging, more pancreatic cysts are likely to be discovered, so gastroenterologists, surgeons, endoscopic ultrasound specialists, and primary

Read more
  • Do Proton Pump Inhibitors Reduce the Need for Phlebotomy in Patients With Hereditary Hemochromatosis?

Do Proton Pump Inhibitors Reduce the Need for Phlebotomy in Patients With Hereditary Hemochromatosis?

In certain patients with hereditary hemochromatosis (HH), treatment with proton pump inhibitors (PPIs) for 2 or more years significantly reduced the number of phlebotomies required to maintain serum levels below 100 μg/L, researchers report in the January issue of Clinical Gastroenterology and Hepatology. HH is one of the most common

Read more
  • Finding Circulating Tumor Cells in Patients With Pancreaticobiliary Cancers

Finding Circulating Tumor Cells in Patients With Pancreaticobiliary Cancers

Circulating tumor cells (CTCs) can be isolated from portal venous blood collected during endoscopic ultrasound (EUS) of patients with pancreaticobiliary cancers, researchers report in the December issue of Gastroenterology. CTCs isolated from peripheral blood of patients with metastatic breast, colorectal, or prostate cancer can be analyzed to predict patient survival. However, blood samples from

Read more